Cargando…
The ADAM17-directed Inhibitory Antibody MEDI3622 Antagonizes Radiotherapy-induced VEGF Release and Sensitizes Non–Small Cell Lung Cancer for Radiotherapy
The cellular response to ionizing radiation (IR) depends on tumor cell and microenvironmental factors. Here, we investigated the role of IR-induced ADAM17 matrix metalloproteinase activity for the intercellular communication between tumor cells and the tumor vasculature in non–small cell lung cancer...
Autores principales: | Tschanz, Fabienne, Bender, Sabine, Telarovic, Irma, Waller, Verena, Speck, Roberto F., Pruschy, Martin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for Cancer Research
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9973400/ https://www.ncbi.nlm.nih.gov/pubmed/36860547 http://dx.doi.org/10.1158/2767-9764.CRC-21-0067 |
Ejemplares similares
-
The role of EphA2 in ADAM17- and ionizing radiation-enhanced lung cancer cell migration
por: Waller, Verena, et al.
Publicado: (2023) -
Interfering with Tumor Hypoxia for Radiotherapy Optimization
por: Telarovic, Irma, et al.
Publicado: (2021) -
The hypoxia-activated prodrug evofosfamide in combination with multiple regimens of radiotherapy
por: Nytko, Katarzyna J., et al.
Publicado: (2017) -
Radiation-induced lymphopenia does not impact treatment efficacy in a mouse tumor model
por: Telarovic, Irma, et al.
Publicado: (2022) -
Tumor suppressor role of miR-3622b-5p in ERBB2-positive cancer
por: Lu, Mingjie, et al.
Publicado: (2017)